{"name":"Symbiomix Therapeutics","slug":"symbiomix-therapeutics","ticker":"","exchange":"","domain":"","description":"","hq":"","founded":0,"employees":"","ceo":"","sector":"","stockPrice":0,"stockChange":0,"stockChangePercent":0,"marketCap":"","metrics":{"revenue":0,"revenueGrowth":0,"grossMargin":0,"rdSpend":0,"netIncome":0,"cash":0,"dividendYield":0,"peRatio":0,"fiscalYear":"FY2026"},"revenueBreakdown":[],"timeline":[{"date":"2026-07-28","label":"Q2 2026 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2026-10-28","label":"Q3 2026 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-01-28","label":"Q4 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-04-28","label":"Q1 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-07-28","label":"Q2 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-10-28","label":"Q3 2027 Earnings","type":"earnings","sentiment":"neutral"}],"diseaseAreas":[],"pipeline":[],"recentEvents":[],"realNews":[{"url":"https://news.google.com/rss/articles/CBMijAFBVV95cUxPaDg4NlVJNF9WT2FYZkU3YTRlMkNVQlhJbkNWRVgyeFR1RVJVZGRrdW4xdTJKWjVIVTdfWV9VcHQ5bUZhWVhFTmJBS0NaRE9SZUpLRktoU1VPLWNpcHI0NWh6dFZYUFlyUnlodjNtQmNQbVdwd3BkdFhuVHgzNGp4ZVlVT2FmcS03M1Izbw?oc=5","date":"2026-02-08","type":"deal","source":"lupin.com","summary":"Lupin Acquires Symbiomix Therapeutics LLC - Lupin | Press Release - lupin.com","headline":"Lupin Acquires Symbiomix Therapeutics LLC - Lupin | Press Release","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMipwFBVV95cUxPcjZrMlAyZHltZGc3RlR4OEwzcjdOVjNOYnVHeFFLcS1URG5fQm1XdnhFRkJEdmFsVlhsYk1PbTVuT29rcXZNWkhVTkJQaWVqQUozcDJISmI3OVdiVWh5dGRzTmNtQ0llVEpUbHhIM19jVnVJUXB2SXZhSTI3THRCakpYUkxYMkdsZW5GQTNmbDl5cTF0YWFPd2hBUlRJUUtwQXJuYzkwRQ?oc=5","date":"2026-02-07","type":"pipeline","source":"lupin.com","summary":"Lupin launches Solosec™ (secnidazole) 2g Oral Granules in the US - Lupin | Press Release - lupin.com","headline":"Lupin launches Solosec™ (secnidazole) 2g Oral Granules in the US - Lupin | Press Release","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMikgFBVV95cUxPRlhwT0N6TkxkZW50RGU4ejZxOG1COEJpcDJZek9leWE3c2IxdFpQNnJlRmJoZEdLd2lnamM5Rm45RGVRX2VqaDF1STJ3WWYyZ2VoMjFzWFV1MTFLbUJua09vNjkxTkg4bDZVTHlvaVlNSUxnNmpCbURycXVhalgwcldUd0pRRUZzVEFBV0QyaHJ5Zw?oc=5","date":"2022-04-29","type":"regulatory","source":"drugdiscoverytrends.com","summary":"FDA approves first drug for chronic yeast infection - drugdiscoverytrends.com","headline":"FDA approves first drug for chronic yeast infection","sentiment":"positive"},{"url":"https://news.google.com/rss/articles/CBMiogFBVV95cUxPUF93N2JPOWxyamMtclB0Zkt4MjdoR2ZvQ3ptanBTNnFzdlBaaFc3em9SdlNhQVVsRHdTVVJMQ0R4bUtYeXBoS2ZHbEFzaDQ0aUgyY0c3UGhPYWNYQ19BNWFxWGlJY3ZLYVFDMHZnWHpkWjZ1bkowdVFkdVQ5M1MwQWZjaHI1cUtYNl9QWEVoN0xtajFEejdienBXdDBycjR5LUE?oc=5","date":"2022-04-08","type":"trial","source":"Clinical Trials Arena","summary":"Solosec (secnidazole) for the Treatment of Bacterial Vaginosis and Trichomoniasis - Clinical Trials Arena","headline":"Solosec (secnidazole) for the Treatment of Bacterial Vaginosis and Trichomoniasis","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMiogFBVV95cUxNSHczN2ZaZUNUN2k0TDFXMmp1MmRjb1R3QWplcDZtTlRmcHc0eFFOcGUxUWZzMnJuTDhYUUo4VjRSaGZhd2RrV2pTcHVVZzFhRm1TMWU4QUZacWZQOGdEUzZlc19acTllMDlDRVlIVjJwYVZrbXhfSTMwU25wbHlfaXBjWE1GUzg5V1hTNHJ4VnF6RmZPTHliNVpsZ1lDa0tWRkE?oc=5","date":"2018-03-14","type":"regulatory","source":"Fierce Pharma","summary":"#FierceMadness gets serious with 64 drug names, including play-in victors Taltz, Nerlynx - Fierce Pharma","headline":"#FierceMadness gets serious with 64 drug names, including play-in victors Taltz, Nerlynx","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMiekFVX3lxTE82bjN5azZwVVpCbzV5eGpqREIzdlVQSi02NzlXd3BxNzdjWjlQYjRzLVlEOHBxQjlDMzBlOG5HeTVOZml3bkZVbmhTdmJlWGNOcUR2eXZIYS1MYjY5U25Dek4tQml6c2NibENIbGgyRjZxOEp5aHByUXl3?oc=5","date":"2018-01-03","type":"pipeline","source":"C&EN","summary":"A banner year for new drugs - C&EN","headline":"A banner year for new drugs - C&EN","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMioAFBVV95cUxNSlp4SnVxSXF0OE1sdEdyanAtajBwcDY0OUlzZFROOXBQYUVnNFB6TUZOTGd5LTFDbTIxZkIzcFNkT3BEWC0td1pPOXR0WVVzNkowY3VkU0hMeEh4WHhpbmxJR3NLVE1DUDVzM0dDamdidFJ6YS1EU29pWkM2U000YW9QUDFld3dnZVB0Mjdzb2JVTlZGbkhLcEJkR1AwUG9z?oc=5","date":"2017-10-12","type":"earnings","source":"NDTV Profit","summary":"ICICI Securities Hikes Target Price Of Lupin, Sun Pharma - NDTV Profit","headline":"ICICI Securities Hikes Target Price Of Lupin, Sun Pharma","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMihgFBVV95cUxQek96TDhneElEWlZhUVdnQ3lOM1QxY2pPakRpWWd1WVhEenI5NEZQRmlfUmEzbC1VRzJNcndGS2wxSjNZNmUtZk02Q1NKU1NDSWZxODl6Y05KYzFmRzBuNnhfYUg3akZQMjJLTzdpa09rZ1ozQ0lrT1RiYXFRWmphbllUQndYQQ?oc=5","date":"2017-10-11","type":"deal","source":"Genetic Engineering and Biotechnology News","summary":"Lupin Acquires Symbiomix Therapeutics for $150M - Genetic Engineering and Biotechnology News","headline":"Lupin Acquires Symbiomix Therapeutics for $150M","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMieEFVX3lxTE1uZGI2Y0RjYXE3NHY5anN6Q3FwdEN0a29UdXdaaEVuV0kyZzZDVV9FRWt4VU55RExDcERvUXdwV2JvZldwbHF2cVk0b1Jfai1aaW5fSGVMeWlxTk5aZlJFeVEzYTN3cE96MjhnRnVMZUE4Nm5JVXY3Y9IBfkFVX3lxTFBUcjFwVDVkNGd0RndpLXJXRUpnTURVUU41Rno0bUFtbkhKWHg2clhaZVhQZHQ2QXRYaW5OV21JbUdyTzFPc3FXLTZUbW93MDYtQUhvcFBBZGhfeGllRU04ZWJXSURqZHk2V0RXMWRtRHdMTG14Y3FTYnFxa1VqQQ?oc=5","date":"2017-10-11","type":"deal","source":"Express Pharma","summary":"Lupin to acquire Symbiomix Therapeutics - Express Pharma","headline":"Lupin to acquire Symbiomix Therapeutics","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMihAFBVV95cUxQTUZfWFNSMFVqVmc0OVRZTExlX21uR2o2bTYwcG9kVnFETjUxRUJranBDMjloQTZhUFZMOHBpYWg4Y2tLcjFYRXZILTFOaG9DdDJWYnh1U19oYk5lQ1AxWUhoQ2tSNy1jU0RueVlJMTlOUU9yWXNnTWlZeTYyTUV1Q0ZxQ1A?oc=5","date":"2017-10-11","type":"deal","source":"VCCircle","summary":"Lupin buys US-based Symbiomix Therapeutics for $150 mn - VCCircle","headline":"Lupin buys US-based Symbiomix Therapeutics for $150 mn","sentiment":"neutral"}],"patents":[],"drugCount":0,"phaseCounts":{},"enrichmentLevel":2,"visitCount":1,"keyCompetitors":[],"therapeuticFocus":[],"financials":null,"yahoo":null}